Sandoval Elisabeth 4
4 · VYNE Therapeutics Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-01+20,000→ 20,000 totalExercise: $2.33Exp: 2033-12-31→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.